The effectiveness of vaccination against pneumococcal infection in patients with severe bronchial asthma

Introduction. The article discusses topical issues of the use of conjugated 13-valent pneumococcal vaccine Prevenar®13 (PCV13) in patients with severe bronchial asthma (SBA), including those receiving targeted therapy with genetically engineered biological drugs (GEBD). Aim. To study the effectiv...

Full description

Bibliographic Details

Main Authors:	Galina L. Ignatova, Sergey N. Avdeev, Vladimir N. Antonov, Elena V. Blinova
Format:	Artigo
Language:	Russo
Published:	"Consilium Medicum" Publishing house 2024-12-01
Series:	Терапевтический архив
Subjects:	severe bronchial asthma vaccine prophylaxis conjugated vaccine
Online Access:	https://ter-arkhiv.ru/0040-3660/article/viewFile/635985/pdf
Tags:	Add Tag No Tags, Be the first to tag this record!